Skip to content

Posterior Capsule Opacification (PCO) With AcrySof Single-Piece IOL

Prospective Evaluation of Posterior Capsule Opacification in Myopic Eyes 4 Years After AcrySof Single-Piece IOL Implantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00855491
Enrollment
100
Registered
2009-03-04
Start date
2003-07-31
Completion date
2008-11-30
Last updated
2009-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior Capsule Opacification

Keywords

PCO, POCO

Brief summary

The purpose of this study what to evaluate if axial myopia might influence the development of PCO.

Detailed description

We sought to prospectively compare PCO in eyes with myopia in relation to axial length with PCO in eyes with normal axial length, to decipher the role of axial myopia in PCO 4 years after surgery for senile cataract.

Interventions

PROCEDUREPhaco

AcrySof Single-Piece IOL

Sponsors

Iladevi Cataract and IOL Research Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* local residency and presence of a cataract in an otherwise normal eye. * Patients older than 50 years * a dilated pupil after mydriasis * Patients with retinochoroidal atrophy, retinal laser prophylaxis, * hypertension

Exclusion criteria

* nondilating pupil after maximal dilation; * pseudoexfoliation; mature, traumatic, black, or complicated cataracts; * previous intraocular surgery; * previous surgery for glaucoma; * uveitis * diabetes mellitus * Patients who did not give consent preoperatively

Design outcomes

Primary

MeasureTime frame
the percentage area of PCO with posterior capsule opacity (POCO) software4 years

Secondary

MeasureTime frame
the presence of PCO within the central 3-mm zone were noted4 years

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026